Skip to main content
nl
fr
en
Get to know Sciensano
About Sciensano
Sciensano in figures
Sciensano's structure
Contact Sciensano
Our commitment to quality, health, safety and environment
Our commitment to collecting and managing data
Partnerships
Emergency and Response
Working / doing an internship at Sciensano
Jobs
Values and standards
History of Sciensano
2022 Annual report
Donations and bequests
Areas of expertise
List of health topics from A-Z
Health and disease monitoring
Animal Health
Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
Food consumption and food safety
Health and environment
Quality of healthcare
Our services
Analysis request
Data collection
External quality assessment
Control and Safety Assessment
Licensing
Health Information
Health Threats
Projects
Reports & Publications
Press Corner
Search form
Search
Home
In the media
In the media
Quality and effectiveness of vaccines, medicines and medical laboratories
In the media
Sciensano and the belgian universities commit to strengthen their partnership
Sciensano joins a European collaboration for developing vaccine adjuvants
Adjustment of the COVID-19 reporting
Study on the presence of titanium dioxide in face masks: initial findings
Network interruptions on 6/3, 13/3 and 3/4
Cochrane review on the efficacy and safety of HPV vaccines by Sciensano authors
The Belgian Institute of Public Health (WIV-ISP) participates in the development of a new vaccine against rabies and yellow fever
Animal health
Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories
Food consumption and food safety
Health and disease monitoring
Health and environment
Quality of healthcare
QR code
